Immunity to and Prevention of Herpes Zoster:
Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi gators from Asia, Europe, and North America. The mee...
Gespeichert in:
| Weitere Verfasser: | , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Vienna
Springer Vienna
2001
|
| Schriftenreihe: | Archives of Virology. Supplementa
17 |
| Schlagworte: | |
| Online-Zugang: | UBR01 URL des Erstveröffentlichers |
| Zusammenfassung: | Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi gators from Asia, Europe, and North America. The meeting was organized to explore progress made in basic virology and molecular understanding of varicella zoster (VZV), and to provide information on current knowledge of latency of VZV in humans. Updates on the immunology responses of humans to VZV, and a description of the current status of varicella vaccine worldwide were also included. In addition, the possibility of prevent ing zoster in people latently infected with wild-type VZV by immunizing them with varicella vaccine was presented. The papers in this volume include written summaries of most of the presentations given at that conference. Coincidentally but appropriately, the conference marked the twenty-fifth or "silver anniversary" of the first publication of the development and use of live varicella vaccine to prevent varicella, by Takahashi and his colleagues. Because varicella vaccine is the first herpesvirus vaccine licensed in use for humans, it is of special interest to all individuals who studied these pathogens. In view of the interest in developing vaccines against other herpes viruses, there was also a presentation on the current status of vaccines against cytomegaloviruses (CMV) at the conference |
| Beschreibung: | 1 Online-Ressource (VII, 184 p) |
| ISBN: | 9783709162590 |
| DOI: | 10.1007/978-3-7091-6259-0 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046149347 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190906s2001 |||| o||u| ||||||eng d | ||
| 020 | |a 9783709162590 |9 978-3-7091-6259-0 | ||
| 024 | 7 | |a 10.1007/978-3-7091-6259-0 |2 doi | |
| 035 | |a (ZDB-2-SBL)978-3-7091-6259-0 | ||
| 035 | |a (OCoLC)1119104516 | ||
| 035 | |a (DE-599)BVBBV046149347 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 616.9101 |2 23 | |
| 084 | |a YD 7405 |0 (DE-625)153342:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Immunity to and Prevention of Herpes Zoster |c edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher |
| 264 | 1 | |a Vienna |b Springer Vienna |c 2001 | |
| 300 | |a 1 Online-Ressource (VII, 184 p) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Archives of Virology. Supplementa |v 17 | |
| 520 | |a Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi gators from Asia, Europe, and North America. The meeting was organized to explore progress made in basic virology and molecular understanding of varicella zoster (VZV), and to provide information on current knowledge of latency of VZV in humans. Updates on the immunology responses of humans to VZV, and a description of the current status of varicella vaccine worldwide were also included. In addition, the possibility of prevent ing zoster in people latently infected with wild-type VZV by immunizing them with varicella vaccine was presented. The papers in this volume include written summaries of most of the presentations given at that conference. Coincidentally but appropriately, the conference marked the twenty-fifth or "silver anniversary" of the first publication of the development and use of live varicella vaccine to prevent varicella, by Takahashi and his colleagues. Because varicella vaccine is the first herpesvirus vaccine licensed in use for humans, it is of special interest to all individuals who studied these pathogens. In view of the interest in developing vaccines against other herpes viruses, there was also a presentation on the current status of vaccines against cytomegaloviruses (CMV) at the conference | ||
| 650 | 4 | |a Virology | |
| 650 | 4 | |a Microbiology | |
| 650 | 4 | |a Medical Microbiology | |
| 650 | 4 | |a General Practice / Family Medicine | |
| 650 | 4 | |a Neurology | |
| 650 | 4 | |a Medical virology | |
| 650 | 4 | |a Microbiology | |
| 650 | 4 | |a Family medicine | |
| 650 | 4 | |a Neurology | |
| 650 | 0 | 7 | |a Impfung |0 (DE-588)4026656-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gürtelrose |0 (DE-588)4158514-8 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)1071861417 |a Konferenzschrift |y 1999 |z Osaka |2 gnd-content | |
| 689 | 0 | 0 | |a Gürtelrose |0 (DE-588)4158514-8 |D s |
| 689 | 0 | 1 | |a Impfung |0 (DE-588)4026656-4 |D s |
| 689 | 0 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Gershon, Anne A. |4 edt | |
| 700 | 1 | |a Arvin, Ann M. |4 edt | |
| 700 | 1 | |a Calisher, Charles H. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783211835555 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783211835562 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783709162606 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-7091-6259-0 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SBL | ||
| 940 | 1 | |q ZDB-2-SBL_2000/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031529524 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1007/978-3-7091-6259-0 |l UBR01 |p ZDB-2-SBL |q ZDB-2-SBL_2000/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180490833362944 |
|---|---|
| any_adam_object | |
| author2 | Gershon, Anne A. Arvin, Ann M. Calisher, Charles H. |
| author2_role | edt edt edt |
| author2_variant | a a g aa aag a m a am ama c h c ch chc |
| author_facet | Gershon, Anne A. Arvin, Ann M. Calisher, Charles H. |
| building | Verbundindex |
| bvnumber | BV046149347 |
| classification_rvk | YD 7405 |
| collection | ZDB-2-SBL |
| ctrlnum | (ZDB-2-SBL)978-3-7091-6259-0 (OCoLC)1119104516 (DE-599)BVBBV046149347 |
| dewey-full | 616.9101 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.9101 |
| dewey-search | 616.9101 |
| dewey-sort | 3616.9101 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1007/978-3-7091-6259-0 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03837nmm a2200637zcb4500</leader><controlfield tag="001">BV046149347</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190906s2001 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783709162590</subfield><subfield code="9">978-3-7091-6259-0</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-7091-6259-0</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SBL)978-3-7091-6259-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1119104516</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046149347</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.9101</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YD 7405</subfield><subfield code="0">(DE-625)153342:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immunity to and Prevention of Herpes Zoster</subfield><subfield code="c">edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Vienna</subfield><subfield code="b">Springer Vienna</subfield><subfield code="c">2001</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (VII, 184 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Archives of Virology. Supplementa</subfield><subfield code="v">17</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi gators from Asia, Europe, and North America. The meeting was organized to explore progress made in basic virology and molecular understanding of varicella zoster (VZV), and to provide information on current knowledge of latency of VZV in humans. Updates on the immunology responses of humans to VZV, and a description of the current status of varicella vaccine worldwide were also included. In addition, the possibility of prevent ing zoster in people latently infected with wild-type VZV by immunizing them with varicella vaccine was presented. The papers in this volume include written summaries of most of the presentations given at that conference. Coincidentally but appropriately, the conference marked the twenty-fifth or "silver anniversary" of the first publication of the development and use of live varicella vaccine to prevent varicella, by Takahashi and his colleagues. Because varicella vaccine is the first herpesvirus vaccine licensed in use for humans, it is of special interest to all individuals who studied these pathogens. In view of the interest in developing vaccines against other herpes viruses, there was also a presentation on the current status of vaccines against cytomegaloviruses (CMV) at the conference</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">General Practice / Family Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical virology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Microbiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Family medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neurology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gürtelrose</subfield><subfield code="0">(DE-588)4158514-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1999</subfield><subfield code="z">Osaka</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Gürtelrose</subfield><subfield code="0">(DE-588)4158514-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Impfung</subfield><subfield code="0">(DE-588)4026656-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gershon, Anne A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arvin, Ann M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calisher, Charles H.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783211835555</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783211835562</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783709162606</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-7091-6259-0</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SBL</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SBL_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031529524</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-7091-6259-0</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SBL</subfield><subfield code="q">ZDB-2-SBL_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)1071861417 Konferenzschrift 1999 Osaka gnd-content |
| genre_facet | Konferenzschrift 1999 Osaka |
| id | DE-604.BV046149347 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:36Z |
| institution | BVB |
| isbn | 9783709162590 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031529524 |
| oclc_num | 1119104516 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (VII, 184 p) |
| psigel | ZDB-2-SBL ZDB-2-SBL_2000/2004 ZDB-2-SBL ZDB-2-SBL_2000/2004 |
| publishDate | 2001 |
| publishDateSearch | 2001 |
| publishDateSort | 2001 |
| publisher | Springer Vienna |
| record_format | marc |
| series2 | Archives of Virology. Supplementa |
| spelling | Immunity to and Prevention of Herpes Zoster edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher Vienna Springer Vienna 2001 1 Online-Ressource (VII, 184 p) txt rdacontent c rdamedia cr rdacarrier Archives of Virology. Supplementa 17 Under sponsorship of the National Institutes of Health of Japan, an international conference entitled "Immunity and Prevention of Herpes Zoster" was held in 1 Osaka, Japan, March 8-10, 1999. Attendees included basic and clinical investi gators from Asia, Europe, and North America. The meeting was organized to explore progress made in basic virology and molecular understanding of varicella zoster (VZV), and to provide information on current knowledge of latency of VZV in humans. Updates on the immunology responses of humans to VZV, and a description of the current status of varicella vaccine worldwide were also included. In addition, the possibility of prevent ing zoster in people latently infected with wild-type VZV by immunizing them with varicella vaccine was presented. The papers in this volume include written summaries of most of the presentations given at that conference. Coincidentally but appropriately, the conference marked the twenty-fifth or "silver anniversary" of the first publication of the development and use of live varicella vaccine to prevent varicella, by Takahashi and his colleagues. Because varicella vaccine is the first herpesvirus vaccine licensed in use for humans, it is of special interest to all individuals who studied these pathogens. In view of the interest in developing vaccines against other herpes viruses, there was also a presentation on the current status of vaccines against cytomegaloviruses (CMV) at the conference Virology Microbiology Medical Microbiology General Practice / Family Medicine Neurology Medical virology Family medicine Impfung (DE-588)4026656-4 gnd rswk-swf Gürtelrose (DE-588)4158514-8 gnd rswk-swf 1\p (DE-588)1071861417 Konferenzschrift 1999 Osaka gnd-content Gürtelrose (DE-588)4158514-8 s Impfung (DE-588)4026656-4 s 2\p DE-604 Gershon, Anne A. edt Arvin, Ann M. edt Calisher, Charles H. edt Erscheint auch als Druck-Ausgabe 9783211835555 Erscheint auch als Druck-Ausgabe 9783211835562 Erscheint auch als Druck-Ausgabe 9783709162606 https://doi.org/10.1007/978-3-7091-6259-0 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Immunity to and Prevention of Herpes Zoster Virology Microbiology Medical Microbiology General Practice / Family Medicine Neurology Medical virology Family medicine Impfung (DE-588)4026656-4 gnd Gürtelrose (DE-588)4158514-8 gnd |
| subject_GND | (DE-588)4026656-4 (DE-588)4158514-8 (DE-588)1071861417 |
| title | Immunity to and Prevention of Herpes Zoster |
| title_auth | Immunity to and Prevention of Herpes Zoster |
| title_exact_search | Immunity to and Prevention of Herpes Zoster |
| title_full | Immunity to and Prevention of Herpes Zoster edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher |
| title_fullStr | Immunity to and Prevention of Herpes Zoster edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher |
| title_full_unstemmed | Immunity to and Prevention of Herpes Zoster edited by Anne A. Gershon, Ann M. Arvin, Charles H. Calisher |
| title_short | Immunity to and Prevention of Herpes Zoster |
| title_sort | immunity to and prevention of herpes zoster |
| topic | Virology Microbiology Medical Microbiology General Practice / Family Medicine Neurology Medical virology Family medicine Impfung (DE-588)4026656-4 gnd Gürtelrose (DE-588)4158514-8 gnd |
| topic_facet | Virology Microbiology Medical Microbiology General Practice / Family Medicine Neurology Medical virology Family medicine Impfung Gürtelrose Konferenzschrift 1999 Osaka |
| url | https://doi.org/10.1007/978-3-7091-6259-0 |
| work_keys_str_mv | AT gershonannea immunitytoandpreventionofherpeszoster AT arvinannm immunitytoandpreventionofherpeszoster AT calishercharlesh immunitytoandpreventionofherpeszoster |